Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 80 billion doses of nearly 8,000 products annually. Its rapidly growing expert workforce exceeds 18,000, including more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, Catalent, Inc. (NYSE:CTLT), is in S&P 500® company, and generated nearly $5 billion in revenue in its 2022 fiscal year.
Products & Services
Abiraterone Acetate
Accutane 10mg 40mg
Acetaminophen
Acyclovir
Sites
Catalent Italy S.p.A
Country
ItalyCity
Aprilia
Address
Via Nettunense Km.20,100, 04011
Gold
2024 Qualifyze Quality Compliance Rating2024 Qualifyze QCRCatalent Italy S.p.A
Audited
Country
ItalyCity
Aprilia
Address
Via Nettunense Km.20,100, 04011
Catalent Japan K.K.
Country
JapanCity
Kakegawa
Address
1656 Kurami, 436-0341
Catalent Belgium S.A.
Country
BelgiumCity
Brussels
Address
Font Saint Landry 10, 1120
Catalent France Beinheim SA
Country
FranceCity
Beinheim
Address
Rue Principale 74, 67930